A drug to treat hepatitis C

Abstract

The invention relates to a medicine for treating hepatitis C. The medicine for treating the hepatitis C is prepared by a method comprising the following steps: soaking periplaneta americana in ethanol which is 60-95% in concentration; conducting ultrasonic extraction at 30-50 DEG C for 3-5 times; decompressing and concentrating obtained extracting solutions; adding water to obtained concentrated periplaneta americana ethanol liquid, stirring the concentrated liquid, preserving heat and standing by until the concentrated liquid is layered; decompressing and concentrating obtained lower water liquid, so that a periplaneta americana extractum for treating the hepatitis C is obtained; and drying and crushing the extractum so as to a a periplaneta americana extract for treating the hepatitis C, uniformly mixing the periplaneta americana extract and ribavirin at the ratio of 1-4: 5, and adding a pharmaceutically acceptable carrier, so that the medicine for treating the hepatitis C is prepared. The medicine can take an inhibitory effect on hepatitis C viruses, remove the viruses, relieve hepatic inflammation activity and fibrosis and prevent the further development of the hepatitis C into liver cirrhosis, and moreover, the medicine can promote the tissue regeneration of hepatic cells, accelerate exfoliation of necrotic hepatic cells and repair damaged hepatic cells at a high speed, so that purposes of repairing and protecting liver and curing the hepatitis C are achieved.

Description

technical field [0001] The invention relates to a medicine preparation method, in particular to a medicine for treating hepatitis C and a preparation method thereof. Background technique [0002] Hepatitis C is a viral hepatitis caused by hepatitis C virus (HCV) infection, which is mainly transmitted through blood transfusion, acupuncture, drug abuse, etc. According to the statistics of the World Health Organization, the global HCV infection rate is about 3%, estimated to be about 180 million People are infected with HCV, and about 35,000 new cases of hepatitis C occur each year. Hepatitis C is a global epidemic, which can lead to chronic inflammation, necrosis and fibrosis of the liver, and some patients can develop liver cirrhosis and even hepatocellular carcinoma (HCC). Cirrhosis is a common chronic liver disease. A variety of reasons cause liver damage, and the liver is progressive, diffuse, and fibrous. The specific manifestation is diffuse degeneration and necrosis ...

AI Technical Summary

Problems solved by technology

[0004] In recent years, many companies at home and abroad have also made great progress in the research on the treatment of hepatitis C. However, there is still no imported or self-developed oral hepatitis C treatment in China. Therefore, for Chinese patients, there are high costs and difficulties in purchasing. Problems, due to these shortcomings, in order to meet the needs of patients with hepatitis C infection in my country, it is imperative to develop an innovative drug that is effective, inexpensive, and has low side effects for the treatment of hepatitis C.